RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Total assets

AbbVie Inc.ABBV

Market cap
$405.4B
P/E ratio
SummaryFinancials
Period EndTotal assets (Million USD)YoY (%)
Dec 31, 2024135,161+0.33%
Dec 31, 2023134,711-2.95%
Dec 31, 2022138,805-5.27%
Dec 31, 2021146,529-2.68%
Dec 31, 2020150,565+68.96%
Dec 31, 201989,115+50.15%
Dec 31, 201859,352-16.15%
Dec 31, 201770,786+7.09%
Dec 31, 201666,099+24.60%
Dec 31, 201553,050+92.58%
Dec 31, 201427,547-5.65%
Dec 31, 201329,198

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)